Levofloxacina Generis

Levofloxacin, the active ingredient in Levofloxacina Generis, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Levofloxacina Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary, abdominal and skin systems.

- Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications. - Complicated urinary tract infections: eliminates resistant uropathogens and resolves infection. - Complicated intra‑abdominal infections: provides broad‑spectrum coverage for mixed bacterial flora. - Skin and soft‑tissue infections: treats cellulitis, abscesses and other bacterial skin conditions.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis after antibiotic use. - Hepatic toxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Levofloxacina Generis, clinicians should consider several safety measures.

- Assess renal function: dose adjustment may be needed in impaired kidneys. - Avoid in patients with known hypersensitivity to fluoroquinolones. - Use with caution in the elderly: higher risk of tendon injury and CNS effects. - Monitor for tendon pain or swelling: discontinue if symptoms appear. - Avoid concomitant use with other QT‑prolonging agents. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Levofloxacina Generis can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Co‑administration with systemic fluoroquinolones: additive toxicity. - Concurrent use with tizanidine: may cause severe hypotension. - Combination with other QT‑prolonging drugs (e.g., macrolides, antipsychotics): increased arrhythmia risk. - Use with non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened central nervous system side effects.

Moderate Interactions (Monitor Closely): - Corticosteroids: elevated risk of tendon rupture. - Theophylline: levofloxacin may increase plasma theophylline levels. - Warfarin: potential enhancement of anticoagulant effect, requiring INR monitoring.